Cargando…
Efficacy of Abemaciclib in the Management of Refractory Metastatic Extramammary Paget’s Disease
Published systemic therapy options for metastatic extramammary Paget's disease have largely been anecdotal due to the rarity of this disease, which has precluded the ability to conduct clinical trials. We describe the favorable response of a 72-year-old man with extramammary Paget's diseas...
Autores principales: | Takahashi, Gary W, Vetto, John, Leitenberger, Justin J, Hung, Arthur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428388/ https://www.ncbi.nlm.nih.gov/pubmed/36060324 http://dx.doi.org/10.7759/cureus.27534 |
Ejemplares similares
-
Scrotal Extramammary Paget’s Disease in an Elderly Caucasian Male
por: Barrera, Jaimie M, et al.
Publicado: (2022) -
The Outcome of Chemotherapy for Metastatic Extramammary Paget’s Disease
por: Hashimoto, Hiroki, et al.
Publicado: (2021) -
Extramammary Paget’s disease
por: Vasquez, Andres, et al.
Publicado: (2016) -
A Likely Case of Abemaciclib-Induced Hyperpigmentation in a Patient With Metastatic Breast Cancer
por: Salusti-Simpson, Michela, et al.
Publicado: (2022) -
Extramammary Perianal Paget's Disease
por: Al Hallak, M.N., et al.
Publicado: (2009)